Sara Mohsen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sara Mohsen has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Amna Zar
College of Medicine, QU Health, Qatar University, Doha P.O. Box 2713, Qatar
2 shared publications Humam Rajha
1 shared publication- Layla Al-Mansoori
Biomedical Research Center (BRC), Qatar University, Doha, Qatar
1 shared publication - Mooza Kh. Al-Hail
College of Medicine, QU Health, Qatar University, Doha P.O. Box 2713, Qatar
1 shared publication - Nour M. Darwish
Biomedical Research Centre, Qatar University, Doha P.O. Box 2713, Qatar
1 shared publication - Rafif Mahmood Al Saady
College of Medicine, QU Health, Qatar University, Doha, Qatar
1 shared publication
Latest Publications
- Open Access
- 25 March 2024
- Published by IntechOpen
Microbiology and Antimicrobial Resistance in Diabetic Foot Infections
Diabetic foot infections (DFIs) can be caused by a wide range of microorganisms, including mainly bacteria and fungi. This class of infections poses significant medical challenges, affecting a large proportion of individuals with diabetic foot ulcers (DFUs). This chapter aims to provide a comprehensive overview of the primary microorganisms responsible for diabetic foot infections, elucidating their virulence factors, pathogenesis, and susceptibility to antimicrobial agents. It also explores the impact of antimicrobial resistance (AMR) on diabetic foot infections (DFIs), highlighting the role of biofilms in chronic diabetic foot infections and the resulting treatment difficulties, all with the goal of reducing complications. By gaining insight into the diverse spectrum of microorganisms involved in diabetic foot infections, healthcare professionals can customize treatment plans for individual patients, ultimately improving patient outcomes and quality of life.
- 25 March 2024
- Published by IntechOpen
Open AccessMicrobiology and Antimicrobial Resistance in Diabetic Foot Infections
Diabetic foot infections (DFIs) can be caused by a wide range of microorganisms, including mainly bacteria and fungi. This class of infections poses significant medical challenges, affecting a large proportion of individuals with diabetic foot ulcers (DFUs). This chapter aims to provide a comprehensive overview of the primary microorganisms responsible for diabetic foot infections, elucidating their virulence factors, pathogenesis, and susceptibility to antimicrobial agents. It also explores the impact of antimicrobial resistance (AMR) on diabetic foot infections (DFIs), highlighting the role of biofilms in chronic diabetic foot infections and the resulting treatment difficulties, all with the goal of reducing complications. By gaining insight into the diverse spectrum of microorganisms involved in diabetic foot infections, healthcare professionals can customize treatment plans for individual patients, ultimately improving patient outcomes and quality of life.
- Open Access
The Role of Apolipoproteins in the Commonest Cancers: A Review
Apolipoproteins (APOs) are vital structural components of plasma lipoproteins that are involved in lipid metabolism and transport. Recent studies have reported an association between apolipoprotein dysregulation and the onset of a variety of human cancers; however, the role of certain APOs in cancer development remains unknown. Based on recent work, we hypothesize that APOs might be involved in the onset of cancer, with a focus on the most common cancers, including breast, lung, gynecological, colorectal, thyroid, gastric, pancreatic, hepatic, and prostate cancers. This review will focus on the evidence supporting this hypothesis, the mechanisms linking APOs to the onset of cancer, and the potential clinical relevance of its various inhibitors.
Open AccessThe Role of Apolipoproteins in the Commonest Cancers: A Review
Apolipoproteins (APOs) are vital structural components of plasma lipoproteins that are involved in lipid metabolism and transport. Recent studies have reported an association between apolipoprotein dysregulation and the onset of a variety of human cancers; however, the role of certain APOs in cancer development remains unknown. Based on recent work, we hypothesize that APOs might be involved in the onset of cancer, with a focus on the most common cancers, including breast, lung, gynecological, colorectal, thyroid, gastric, pancreatic, hepatic, and prostate cancers. This review will focus on the evidence supporting this hypothesis, the mechanisms linking APOs to the onset of cancer, and the potential clinical relevance of its various inhibitors.